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Abstract
PURPOSE: The purpose of this project was to measure adherence rates to the current
alcohol use screening process, and identification of correlations of alcohol use and
outcomes in patients admitted to Norton Hospital, via the emergency department.
METHODS: The study design is a retrospective descriptive evaluation, of adherence to
the current alcohol use screening process, and associations among age, gender, ethnicity,
length of stay, number of ICU days, restraint use days, level of care at admission (ICU,
TCU, LLM/tele, MS), incidence of AWS/DTs, and activation of the CIWA protocol
among the adult inpatient population of Norton Hospital’s downtown campus, admitted
via the emergency department (ED), for greater than 24 hours, between April 2016 and
April 2017. The sample consisted of 300 randomly selected patient charts, using the
inclusion criteria.
RESULTS: It was found that overall screening adherence for alcohol use on patients
admitted from the emergency room was nearly 100%. Among the study population
26.3% screened positive, 4.3% had the specific diagnosis of alcohol withdrawal
syndrome, 4.7% were treated with CIWA protocol. Those who screened positive were
more likely to be male, with a mean age of 49.8 years. No statistical differences in
ethnicity, level of care at admission, restraint use, mortality, number of ICU days, and
length of stay were found within the study sample population, between those who
screened positive or negative for alcohol use at admission.
CONCLUSION: Further research needs to be done to better understand associations
between alcohol use screening and ethnicity, level of care at admission, restraint use,
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length of stay, number of ICU days and mortality in the overall population at Norton
Hospital’s downtown campus. Retrospective review revealed that there was a high level
of adherence to the alcohol use screening process by the health care staff. The screening
process for alcohol use at admission is well documented within those admitted via the
emergency department.
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Assessment of Alcohol Withdrawal Syndrome Incidence and Identification of Other Correlating
Risk Factors in Patients Admitted Through the Emergency Department
Introduction
With alcohol and substance abuse problems continuing to rise rapidly throughout our
nation, we are in need of a way to ensure proper identification and treatment of alcohol
withdrawal syndrome in persons who present to the emergency department, and undergo an
abrupt cessation of alcohol consumption due to an acute illness, and hospitalization. This study
is designed to determine if there was adherence to an established alcohol use screening process
during the time frame, ensuring that those who are at risk for the development of alcohol
withdrawal syndrome are being treated with the Clinical Institute Withdrawal Assessment
(CIWA) protocol, and to determine correlating risk factors and demographics. This study was
designed with alignment of Neuman’s Systems Model nursing theory. Treating the patient as a
fluid and dynamic being responding to their own personal environment leading to sickness and
establishing health, using primary, secondary and tertiary care interventions. Focusing on the
patient as a whole, with multidimensional, layers of well-being: physiological, physiochemical,
psychological, sociocultural and spiritual (Petiprin, 2016).
Background
As the problem with alcohol abuse and other substances continues to grow exponentially
throughout our nation, and in particular in the state of Kentucky, we have seen a steady rise of
alcohol withdrawal syndrome (AWS) incidence within the general hospital inpatient population.
Approximately 9% of the adults in the United States meet the criteria for alcohol abuse (Burns,
2015). Within the general inpatient population alcohol withdrawal syndrome (AWS) can present
in nearly 30% of patients; if left untreated AWS has a 15% mortality rate (Ungur, Neuner, John,
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Wernecke, & Spies, 2013). With early recognition and treatment, however, that mortality rate
falls dramatically to 2% (Ungur et al., 2013).
At the downtown campus of the 379 bed Norton Hospital in Louisville, KY, there were
16,768 inpatient admissions in 2015 (US News Health Care Report, 2016). Based on the 30%
incidence of AWS in the general inpatient population, this could have left 5,030 patients at risk,
or 113 patients on any given day for the development of alcohol related complications that year.
By ensuring that patients are screened for alcohol use at the time of hospital admission, a
primary healthcare intervention, we have the opportunity to identify patients at risk for AWS so
that timely prevention and/or treatment, a secondary healthcare intervention, can occur.
The abrupt cessation of alcohol intake by alcohol dependent patients puts them at risk for
withdrawal, and a variety of complications. These include development of AWS, post-operative
complications and infections, increased length of stay and death (Bard et al., 2006). All of which
can upset the balance of the wellness continuum described by Neuman’s Systems Model. This
can also cause problems for the hospital itself. For example the staff can be at risk of burnout,
due to stress from caring for confused and combative patients; also it can be difficult to
determine whether a patient’s confusion is due to AWS or another diagnosis, leading to
increased costs and unnecessary testing (Ungar et al., 2013). In addition, the hospital is at risk
for increased post-operative complication rates, increased length of stay, and increased mortality,
all of which lead to increased costs, and decreased patient and provider satisfaction (Ungar et al.,
2013). In 2016 alone, healthcare costs related to alcohol induced complications in the United
States amounted to $21 billion (Trevejo-Nunez, Kolls, & De Wit, 2016).
Currently, the screening tool for alcohol use at Norton Hospital is a yes or no question
asked during the admission assessment within the admission navigator in the electronic medical

ASSESSMENT OF ALCOHOL WITHDRAWAL SYNDROME

3

record system EPIC. This important screening tool is not linked to prompt the provider to
initiate treatment if the patient screens positive. The current standard of care treatment for AWS
at Norton Hospital is utilized with the Clinical Institute Withdrawal Assessment (CIWA). This
protocol is a thorough nursing assessment done by the bedside nurse, using severity of ten
symptoms of withdrawal, each tied to a number based upon level of severity. These ten numbers
are then added together for an overall composite score. The composite score is then referenced
for the appropriate treatment and frequency of reassessment (Appendix B). If the alcohol use
screening is left undocumented it leaves potentially hundreds of patients at risk for untreated
AWS, and preventable healthcare dollars wasted.
The evidence shows that treatment preventing AWS at the earliest possible juncture, with
a protocol for symptom triggered management such as the CIWA protocol, produces the best
outcomes (Rubinsky et al., 2013; Melson, Kane, Mooney & McWilliams, 2014). These outcomes
include a decrease in the development of AWS and Delirium Tremens (DTs), as well as
decreases in use of restraints, a need for intensive care unit level of care, length of stay, risk of
infections (sepsis, pneumonia, and surgical site), and complications from organ dysfunction
(Melson, et al., 2014; Ungur, et al., 2013).
By screening all patients for alcohol use at admission via the emergency department,
(where a large portion of the inpatient admissions occur at Norton Hospital’s downtown
campus), and ensuring adherence to the documentation of the current method in the admission
navigator under alcohol use screening, we can capture a larger percentage of patients who will
qualify for treatment, and monitor for complications of AWS. In turn reducing alcohol use
related complications and improvement of outcomes such as length of stay, utilization of higher
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levels of care, use of restraints, and mortality. As improvement in these things can reduce health
care cost and increase patient satisfaction.
Purpose
The purpose of this project was to measure adherence rates to the current alcohol use
screening process and identify outcomes (length of hospital stay, number of ICU days, restraint
use, level of care at admission, and mortality), of patients admitted to Norton Hospital. The
adherence to the current alcohol screening process was reviewed via retrospective chart review.
The specific aims of this project were:
1. Measure adherence rate to the current alcohol use screening process, on all
adults (those greater than 18 years of age), admitted as inpatients from the
emergency department (ED), for greater than 24 hours between April 2016
and April 2017.
2. Identify subject demographics (medical record number, age, ethnicity, and
gender), length of stay, number of ICU days, restraint use days, mortality,
level of care at admission (ICU, Telemetry Care [TCU], Monitored MedicalSurgical [LLM/tele] or Non-monitored medical surgical [MS]), incidence of
AWS/DTs, and activation of the CIWA protocol in all adult patients admitted
through the ED, for greater than 24 hours between April 2016 and April 2017.
3. Perform in-group comparisons of subject demographics (age, ethnicity,
gender), length of stay, number of ICU days, restraint use days, mortality,
level of care at admission (ICU, TCU, LLM/tele, or MS), incidence of
AWS/DTs, and activation of the CIWA protocol, among adult patients who
screened positive for alcohol use, patients who screened negative for alcohol
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use, and those patients who were not screened for alcohol use upon admission
from the ED for greater than 24 hours, between April 2016 and April 2017.
Methods
This study was a single-center, retrospective, descriptive evaluation of adherence to the
current alcohol use screening process, and the associations between age, gender, ethnicity, length
of stay, number of ICU days, mortality, level of care at admission, incidence of AWS/DTs, and
the activation of the CIWA protocol, among the adult inpatient population of Norton Hospital
downtown campus, admitted via the ED.
Setting
Norton Hospital is one of five main hospitals of the Norton Healthcare System, and is the
focus of this study. Norton Hospital’s downtown campus is a general medical surgical hospital,
with 379 inpatient beds, located in the urban, downtown area of Louisville, KY (US News Health
Report, 2016). It serves a large population from Jefferson County and many of the outlying,
rural areas. This site was selected for use in this study as it provides care to a wide range of
patients, and has a highly utilized emergency room, from which the patients were selected.
Sample
The primary population for this study consisted of adult inpatients admitted through the ED
for greater than 24 hours between April 2016 and April 2017 at Norton Hospital’s downtown
campus. From this primary population, 300 patients were randomly selected for the study.
To meet inclusion criteria for this study, subjects had to be adults, aged greater than 18 years
and, admitted as inpatients via the ED, for greater than 24 hours to Norton Hospital’s downtown
campus between April 2016 and April 2017.
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Because AWS/DTs occur mostly in the adult population, minors were excluded, from this
study.
Data Collection
Prior to the collection of data, approval was obtained from the University of Kentucky
Institutional Review Board (IRB) and the Norton Healthcare Office of Research and
Administration (NHORA). This study was conducted as a retrospective chart review. The
research office of Norton Healthcare randomly selected patient charts for the study from the
Norton Hospital electronic patient database and sent to the primary investigator. During data
collection, the patient charts were accessed using the patient medical record number, data for the
study were collected, and transferred to an electronic spreadsheet, made by this primary
investigator, using the patients de-identified unique study ID, and the demographic and outcome
variables requested to be collected. The following demographic variables (age, ethnicity, and
gender), and outcome variables (length of stay, number of ICU days, restraint use, restraint use
days, mortality, incidence of AWS/DTs, level of care at admission, activation of the CIWA
protocol, and alcohol use screening documentation) were reviewed.
Data Analysis
Descriptive statistics, including means, standard deviations, ranges, medians, and
percentages were used to describe the patient demographic and outcome variables. Only one
individual was not screened for alcohol use, therefore group comparisons of study variables were
based on those who screened positive versus negative for alcohol use. Continuous variables
were compared between those who screened positive, and those that screened negative for
alcohol use, using the independent sample t-tests. For categorical variables the chi-squared test
of association, or the Fisher’s exact test was used. The Mann-Whitney U-test was used to
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compare groups on length of hospital stay, and number of ICU days outcomes, since the
distributions were skewed. All statistical analysis was done using SPSS version 24 and an alpha
level of .05 was used for statistical significance throughout.
Results
Sample Characteristics
For this study, 300 charts were reviewed from randomly selected patients’ charts meeting
the inclusion criteria. The mean age for the collective sample was 55.9 years old (SD=17.3), and
over half (59.7%; see Table 1) were female. The majority of the population was Caucasian
(55.3%), followed by African-American (43.3%). The largest portion of admissions went to a
TCU level of care (35.3%) and MS (35.3%), followed by ICU (16.7%). The use of restraints
among the sample was low (5.3%). The median length of hospital stay in days was 5 days, (1214 days). Among the 50 patients who were identified as having been in the ICU the median
number of days in ICU was 3 days (1-32). Mortality was high (16.0%) among the sample
population. Only 1 patient was identified as not being screened for alcohol use (eliminating it as
a group for comparison within the study), a majority of the sample was screened negative for
alcohol use (73.3%), followed by those who screened positive for alcohol use (26.3%).
Alcohol Use Screening Adherence
For the collective study sample the adherence rate to the alcohol use screening
documentation was high, at 99.7%; finding that only one patient was not screened at admission.
Approximately one quarter (26.3%) of screened patients yielded a positive result.
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Patient Demographics
The patient demographics collected during this study were age, ethnicity, and gender.
There were no statistical differences found in ethnicity, or age, between those who screened
positive and those who screened negative for alcohol use.
For gender, it was broken into male and female. For the overall study population the
majority of patients were female (59.7%). For those who screened positive for alcohol use
approximately a third were male (33.9%). There was statistical significance (p=.016) that males
were more likely to screen positive for alcohol use, as was concurrent with the literature.
Correlations to outcomes
The following outcome variables were collected in this study: level of care at admission,
length of stay, number of ICU days, use of restraints and length of use, if there was a diagnosis
of AWS/DTs, if the CIWA protocol for withdrawal treatment was activated, and mortality. For
the overall study population 50 patients (16.7%) were admitted to the ICU, 144 patients (48%)
were admitted to the TCU, and 106 patients (35.3%) were admitted to the MS units. For those
who screened positive for alcohol use 16 (20.3%) went to the ICU, 29 (36.7%) went to the TCU,
and 34 (43%) went to MS units. For those who screened negative for alcohol use 34 (15.5%)
went to the ICU, 115 (52.3%) went to the TCU, and 71 (32.3%) went to the MS units. There
was no statistically significant difference (p=.113) for the level of care at admission between
those who screened positive and those who screened negative for alcohol use.
The median length of stay (LOS) for the study population was five days, with a minimum
of one day and the maximum of 214 days. For those who screened positive for alcohol use the
median LOS was four days, with a minimum of one day, and a maximum of 61 days. For those
that screened negative the median LOS was five days, with a minimum of one day, and a
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maximum of 214 days. Using the Mann-Whitney U test it was determined that there was no
significant differences in the two groups (p=.975).
The number of ICU days for the study population was a median of three days, with a
minimum of one day, and a maximum of 32 days. For patients who screened positive for alcohol
use the number of ICU days was a median of two days, with a minimum of one day, and a
maximum of 16 days. For those who screened negative for alcohol use the median number of
ICU days was three days, with a minimum of one day, and a maximum of 32 days. No
statistically significant differences were found between the two groups.
Restraints were used in 16 patients, 5.3% out of the overall study population. Of those
who screened positive for alcohol use there were six patients (7.6%) who were placed in
restraints, for a median of two days. Restraints were used in 10 patients (4.5%), who screened
negative for a median of two days. There was no statistically significant difference in the use of
restraints between the two groups (p=.380).
There were 13 patients (4.3%) with an actual diagnosis of AWS or DTs, all of whom
screened positive for alcohol use, and were treated with the CIWA protocol. Only one patient
who screened negative for alcohol use at admission, was found to actually need treatment for
alcohol withdrawal and was treated with the CIWA protocol within the sample, making a total of
14 patients (4.7%) treated for AWS within the study sample population.
Mortality in the overall study population was shown to be 16.0% (48 patients). Those
who screened positive for alcohol use four patients (5.1%) were deceased at the end of the
hospital admission. For those that screened negative for alcohol use 44 patients (20.0%) were
found to be deceased at the end of hospital admission. There was a significant correlation
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(p=.002) between screening negative for alcohol use and mortality, opposite of the current
literature.
Discussion
This study sought to determine adherence rates for alcohol use screening documentation
on patients admitted to Norton Hospital’s downtown campus via the emergency department. In
addition it sought to measure subject demographics (age, gender and ethnicity), and measure
outcomes including hospital length of stay, number of ICU days, use of restraints and length of
use, incidence of AWS/DTs, level of care at admission, incidence of activation of the CIWA
protocol, and mortality, among the study population. An in-group comparison between those
who screened negative for alcohol use, those who screened positive for alcohol use and, those
who were not screened, was done to determine any associations of outcomes to a particular
group. The results showed that only one person was not screened for alcohol use making that
group obsolete for comparison.
Alcohol Use Screening Documentation Adherence
The rate of adherence to the alcohol use screening documentation within the admission
history was 99.7%. There is a selectable response of yes, no, or not asked, in which the nursing
staff or care treatment team is able to document. This result is very high, showing consistent
adherence, with no need for a performance improvement intervention. Further expansion of the
study population to all methods of admission, not just those from the ED, may yield different
results, and could be examined in another study. Expansion into the primary care setting as well
could help provide insight to the consistency across the entire healthcare continuum and Norton
Healthcare system.
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Alcohol Withdrawal Syndrome Incidence
With adherence to the alcohol use screening at nearly 100%, the hospital was able to
capture 79 patients (26.3%), within the study population who were at risk for developing
AWS/DTs. This aligns closely with the national average of nearly 30% of the inpatient
population (Ungur et al., 2013). In addition 14 patients (16.3%) were determined to need
treatment for withdrawal symptoms using the CIWA protocol. This shows that with high
adherence to screening for alcohol use the treatment team is able to use that information to
provide the earliest, and best care using the CIWA protocol when indicated, producing the best
possible outcomes for patients (Rubinsky et al., 2013; Melson, et al., 2014).
Patient Demographics
Those patients in the study sample population who screened positive for alcohol use were
statistically younger at 49.8 years (p< .001), compared to those that screened negative (58.2
years) and the overall population (55.9 years). This seems to be appropriate and expected, as
younger people consume more alcohol, and more regularly, (Burns, 2015).
There was also evidence that males are more likely to screen positive for alcohol use than
females (p= .016), which is consistent with the literature reviewed, that males tend to participate
in riskier behaviors (Ungar, et al., 2013).
No relationship was found between ethnicity and results of the alcohol use screening in
this study (p=.479). All patients who screened positive for alcohol use were either Caucasian
(55.7%) or African-American (44.3%) in this study. As alcohol misuse is found in all people
regardless of ethnicity, this finding aligns with other research (Ungar, et al., 2013).
In conclusion those patients who screened positive for alcohol use in this study were
males of approximately 50 years of age, and nearly equally distributed among ethnicities.
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Length of Stay/ICU days
In this study it was surprisingly found that those who screened positive for alcohol use
had a shorter length of stay, at four days, compared to five days for those who screened negative.
Though not statistically significant, it is clinically significant and this difference may be due in
part to the population’s method of admission (via the ED), and the patients’ other medical
conditions and primary diagnoses. Another factor that could have influenced the data was that
all 13 patients identified for treatment with the CIWA protocol, screened positive for alcohol use
and treated appropriately, potentially decreasing sequelae from withdrawal and potentiating a
shorter length of stay. Future studies could examine this more closely.
There was found to be no significant difference between a patients’ positive or negative
screening for alcohol use and the number of days they spent in the ICU. For those who screened
positive there was a median of two ICU days, and for those who screened negative there was a
median of three ICU days. This slight difference may be due to patients being treated with the
CIWA protocol when withdrawal was identified, to reduce escalation of care or time needed in
the ICU. This too could be examined more closely in a future study.
Restraint Use Incidence
Although there was a slightly higher incidence of restraint use in those patients who
screened positive for alcohol use (7.6%) compared to, those who screened negative (4.5%), there
was no statistically significant difference (p= .550) between the two groups. This could be due
to a low incidence of restraint use within the overall group, with only 16 patients (5.3%) having
been placed in restraints. Reasoning for placement of restraints could be examined in future
studies to determine if it was due to sequelae of withdrawal, such as delirium or agitation.
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Mortality
Surprisingly, there was a 16% mortality rate among the overall study population, and an
equally shocking finding of a significantly lower mortality rate among those who screened
positive for alcohol use compared to the overall population and to those who screened negative
for alcohol use (p= .002). Those who screened positive for alcohol use had a 5.1% mortality
rate, with only four patients found to be deceased at the end of the hospital admission. Those
who screened negative for alcohol use had a 20.0% mortality rate, with 44 patients found to be
deceased at the end of the hospital admission. There are several factors that may be skewing the
data in this unexpected direction. One factor may be the population itself, as most people
admitted to the hospital from the ED often have more life-threatening diagnoses or substantial
illnesses, than alcohol use or withdrawal. Another factor that may have skewed the data is the
high adherence rate to the alcohol use screening and use of treatment with the CIWA protocol,
which could have decreased the severity of sequelae from withdrawal and reduced the incidence
of life-threatening complications.
Limitations
There were several limitations identified in the design of this study. The first one is the
study’s population being limited to admissions from the ED. Looking at only the ED could have
affected the results of this study in multiple ways, such as the adherence to screening for alcohol
use. It is possible that this particular department is more stringent in documenting this portion of
the admission history, compared to other departments within the hospital. Mortality and length
of stay, including number of ICU days could have been affected by only using admissions from
the ED. Many people who are seen, treated, and admitted by way of the ED have significant or
life-threatening injuries or medical problems, leading to higher rates of death and length of stay,
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compared to other patients. Post-elective surgery patients, for example, have an expected length
of stay and discharge plan. Patients admitted from the ED may not have this.
Another limitation of this study was, using only one of the Norton Healthcare hospitals
that serve this community. Different results may be obtained by using more than one site, as the
other facilities serve patients with some of the same demographics. Future research could
compare between the facilities to ensure that adherence to the screening process for alcohol use
and treatment with the CIWA protocol is similar across the Norton Healthcare system.
Recommendations for Future Studies and Next Steps
The results of this study suggest several opportunities for further research into screening
for alcohol use at admission. It may be helpful to expand the sample population to all methods
of admission, not just via the ED. This would allow a broader look at the population that Norton
Hospital (downtown campus) serves. This could be taken further to include the other Norton
Healthcare facilities, including the primary and immediate care facilities, to ensure system wide
consistency with documentation for alcohol use as well as treatment with the CIWA protocol for
withdrawal, in the hospital setting. Further investigation of the use of the CIWA protocol could
also include the time frame of alcohol use screening at hospital admission, to the time of
activation of the protocol. This could assist with determining how closely these two variables
are correlated.
As well as determining that screening for alcohol use is not just being done within a
hospital admission, and is being monitored and documented within the primary care arena as
well. Many of the patients seen as inpatients access care outside of the hospital itself. The
records of those patients that seek care within the Norton Healthcare system, either in the
hospital, primary care or immediate care setting, are accessible to any provider that sees them
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within the Norton Healthcare system. Allowing ease of follow-up and ability for full review of
all care provided. As screening is a primary healthcare intervention it should also be done prior
to a stressor such as a hospital admission.
A more in depth investigation into some of the variables such as mortality, length of stay,
number of ICU days, and restraint use may be helpful in determining a trend, and/or reasoning
why some of the results of this study were not as expected. For example, why there was lower
mortality within the group that screened positive for alcohol use. This could be done by
collecting data regarding admitting diagnoses and past medical history to determine the comorbidity burden. As well as socioeconomic characteristics, that may impact mortality.
There may also be value in expanding this study to include screening for substance abuse
to determine if there are correlations between alcohol use and substance abuse, and if we are
treating this population with the best evidence based care as well. This is especially relevant as
the number of opioid related deaths and complications continue to rise in this area of the country.
Gathering this data as well could give us as healthcare providers a better insight to the full
spectrum of the underlying problems our patients face. To ensure that we are not just treating
one problem such as alcohol withdrawal, when there are other problems that need to be
addressed in addition, such as opioid misuse and withdrawal, that often complicate treatment
plans. This data can also help to determine the extent of the problems in this community and
provide information about the demands of the community, so that we can help those in need, and
find out how the Norton Healthcare system can provide these services.
Conclusion
The aim of this study was to measure adherence rates to the current alcohol use screening
process and identify outcomes of patients admitted to Norton Hospital via the emergency
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department. In addition, to identify subject demographics (age, ethnicity, and gender), length of
stay, number of ICU days, incidence of restraint use and number of days used, mortality,
incidence of AWS/DTs, and activation of the CIWA protocol.
In-group comparisons of subject demographics (age, ethnicity, gender), length of stay,
number of ICU days, restraint use days, mortality, level of care at admission (ICU, TCU,
LLM/tele, or MS), incidence of AWS/DTs, and activation of the CIWA protocol, among adult
patients who screened positive for alcohol use, patients who screened negative for alcohol use,
and those patients who were not screened for alcohol use upon admission determined that those
who will screen positive for alcohol use are males, with a median age of 49.8 years old. It was
also identified that the adherence rate for screening for alcohol use was nearly 100%, within the
study’s sample population. Surprisingly it was identified that those who screened positive for
alcohol use had a lower mortality rate, and should be examined more in depth in the future. As
well as a more comprehensive dissection of the results regarding length of stay, number of ICU
days, and the use of restraints, as none of these results were found to have statistically significant
differences among those that screened negative and positive for alcohol use.
This study has laid the ground work for future studies about alcohol use screening, and
providing the best evidence-based care to the population served at Norton Hospital’s downtown
campus.
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Table 1. Descriptive summary of ED patients (N=300)

Variable
Age

Mean (SD); median (range); n (%)
55.9 years (17.3)

Gender
Male

121 (40.3%)

Female

179 (59.7%)

Race/Ethnicity
White

166 (55.3%)

African American

130 (43.3%)

Other

4 (1.3%)

Level of care
ICU

50 (16.7%)

TCU

144 (35.3%)

MS

106 (35.3%)

Restraints
Yes

16 (5.3%)

No

284 (94.7%)

Length of hospital stay in days

5 (1-214)

Number of ICU days

3 (1-32)

Mortality
Deceased

48 (16.0%)

Alive

252 (84.0%)

Alcohol screening
Positive

79 (26.3%)

Negative

220 (73.3%)

Not screened

1 (0.3%)

Diagnosis of AWS

13 (4.3%)

Diagnosis of DTs

1 (0.3%)

CIWA protocol activated
Yes

14 (4.7%)
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Table 2. Associations between Demographic Variables, Patient Outcomes, and Alcohol Use Screening (n=299)

Screening positive

Screened negative

(n=79)

(n=220)

Mean (SD) or n (%)

Mean (SD) or n (%)

49.8 years (14.5)

58.2 years (17.8)

<.001

Male

41 (33.9%)

80 (66.1%)

.016

Female

38 (28.3%)

140 (78.7%)

White

44 (55.7%)

122 (55.5%)

African-American

35 (44.3%)

94 (42.7%)

0 (0)

4 (1.8%)

ICU

16 (20.3%)

34 (15.5%)

TCU

29(36.7%)

115 (52.3%)

MS

34 (43.0%

71 (32.3%)

Yes

6 (7.6%)

10 (4.5%)

No

73 (92.4%)

210 (95.5%)

Length of Hospital Stay
in Days

4 (1-61)

5 (1-214)

.975

Number of ICU days

2 (1-16)

3 (1-32)

.994

4 (5.1%)

44 (20.0%)

.002

75 (94.9%)

176 (80.0%)

Age

p

Gender

Race

Other

.479

Level of Care
.113

Restraints
.302

Mortality
Deceased
Alive
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Table 3: Hospital Adherence to Alcohol Use Screening
Variable

Hospital
screening
Adherence
0-20%=0
21-40%=1
41-60%=2
61-80%=3
81-100%=4
Actual %

Overall hospital
adherence rate
(not level of care
separated)
(n=300)
% of screening
done

Admission level
of care ICU
(n=50)

Admission level
of care TCU
(n=144)

Admission level
of care MS
(n=106)

X

X

X

100%
50/50

100%
144/144

99.1%
105/106

99.7%
299/300

ASSESSMENT OF ALCOHOL WITHDRAWAL SYNDROME
Appendix A

Data Collection Tool for Patient Information

Variable
Patient 1A
Age
Actual age
Sex
Male=0
Female=1
Ethnicity
White=1
AfricanAmerican=2
Other/unknown=3
Alcohol use
Yes=0
No=1
Not documented=2
Length of Stay
(days)
Actual number of
days
CIWA protocol
activated
Yes=0
No=1
Number ICU days
Actual # of days (if
applicable)
Restraints
Yes=0
No=1
# of days used
Diagnosis of AWS
Yes=0
No=1
Diagnosis of DTs
Yes=0
No=1
Mortality
Deceased=0
Alive=1
Level of care at
admission
ICU=0
TCU=1
MMS=2
MS=3

23

Patient 1B

Patient 1C

Patient 1D
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Appendix B
Alcohol Withdrawal Assessment Scoring Guidelines (CIWA - Ar)
Nausea/Vomiting - Rate on scale 0 - 7

0 - None
1 - Mild nausea with no vomiting 2
3

Tremors - have patient extend arms & spread fingers. Rate on scale 0 - 7.

0 - No tremor
1 - Not visible, but can be felt fingertip to fingertip 2
3
4 - Moderate, with patient’s arms extended 5

4 - Intermittent nausea 5

6

6
7 - severe, even w/ arms not extended

7 - Constant nausea and frequent dry heaves and vomiting

Anxiety - Rate on scale 0 7 0 - no anxiety, patient at
ease 1 - mildly anxious

Agitation - Rate on scale 0
- 7 0 - normal activity

2

1 - somewhat normal
activity 2

3

3

4 - moderately anxious or guarded, so anxiety is
inferred 5

4 - moderately fidgety and
restless 5

Paroxysmal Sweats - Rate on Scale 0 - 7.
0 - no sweats

1- barely perceptible sweating, palms
moist 2

Orientation and clouding of sensorium - Ask, “What day is
this? Where are you? Who am I?” Rate scale 0 - 4
0 - Oriented
1 – cannot do serial additions or is uncertain about date

3

2 - disoriented to date by no more than 2

4 - beads of sweat obvious on
forehead 5

calendar days 3 - disoriented to date by more

Tactile disturbances - Ask, “Have you experienced any
itching, pins & needles sensation, burning or numbness,
or a feeling of bugs crawling on or under your skin?”
0 - none
1 - very mild itching, pins & needles, burning, or

numbness 2 - mild itching, pins & needles, burning,
or numbness
3 - moderate itching, pins & needles, burning, or
numbness 4 - moderate hallucinations
Visual disturbances - Ask, “Does the light appear to be
too bright? Is its color different than normal? Does it
hurt your eyes? Are you seeing anything that disturbs
you or that you know isn’t there?”
0 - not present
1 - very mild

sensitivity 2 - mild
sensitivity
3 - moderate sensitivity
4 - moderate
hall cinations 5 se ere

Auditory Disturbances - Ask, “Are you more aware of
sounds around you? Are they harsh? Do they startle you?
Do you hear anything that disturbs you or that you know
isn’t there?”
0 - not present
1 - Very mild harshness or ability to

startle 2 - mild harshness or ability to
startle
3 - moderate harshness or ability to
startle 4 moderate hallucinations
Headache - Ask, “Does your head feel different than
usual? Does it feel like there is a band around your head?”
Do not rate dizziness or lightheadedness.
0 - not present
1 - very mild
2 - mild
3 - moderate
4 - moderately

severe 5 severe
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Procedure:
1. Assess and rate each of the 10 criteria of the CIWA scale. Each criterion is rated on a scale from 0 to 7, except for “Orientation and clouding of sensorium” which is
rated on scale 0 to 4. Add up the scores for all ten criteria. This is the total CIWA-Ar score for the patient at that time. Prophylactic medication should be started for any
patient with a total CIWA-Ar score of 8 or greater (ie. start on withdrawal medication). If started on scheduled medication, additional PRN medication should be given
for a total CIWA-Ar score of 15 or greater.
2. Document vitals and CIWA-Ar assessment on the Withdrawal Assessment Sheet. Document administration of PRN medications on the assessment sheet as well.
3. The CIWA-Ar scale is the most sensitive tool for assessment of the patient experiencing alcohol withdrawal. Nursing assessment is vitally important. Early intervention
for CIWA-Ar score of 8 or greater provides the best means to prevent the progression of withdrawal.
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Assessment Protocol
a. Vitals, Assessment Now.
b. If initial score ≥ 8 repeat q1h x 8
hrs, then if stable q2h x 8 hrs, then
if stable q4h.
c. If initial score < 8, assess q4h x 72
hrs. If score < 8 for 72 hrs, d/c
assessment. If score ≥ 8 at any
time, go to (b) above.
d. If indicated, (see indications below)
administer prn medications as
ordered and record on MAR and
below.

Date
Time

Pulse
RR
O2 sat
BP

Assess and rate each of the following (CIWA-Ar Scale):

Nausea/vomiting (0 - 7)
0 - none; 1 - mild nausea ,no vomiting; 4 - intermittent
nausea; 7 - constant nausea , frequent dry heaves &
vomiting.

Tremors (0 - 7)
0 - no tremor; 1 - not visible but can be felt; 4 - moderate
w/ arms extended; 7 - severe, even w/ arms not extended.

Anxiety (0 - 7)
0 - none, at ease; 1 - mildly anxious; 4 - moderately
anxious or guarded; 7 - equivalent to acute panic state

Agitation (0 - 7)
0 - normal activity; 1 - somewhat normal activity; 4 moderately fidgety/restless; 7 - paces or constantly
thrashes about

Paroxysmal Sweats (0 - 7)
0 - no sweats; 1 - barely perceptible sweating, palms
moist; 4 - beads of sweat obvious on forehead; 7 drenching sweat

Orientation (0 - 4)
0 - oriented; 1 - uncertain about date; 2 - disoriented to
date by no more than 2 days; 3 - disoriented to date by >
2 days;
4 - disoriented to place and / or person

Tactile Disturbances (0 - 7)
0 - none; 1 - very mild itch, P&N, ,numbness; 2-mild
itch, P&N, burning, numbness; 3 - moderate itch, P&N,
burning ,numbness; 4 - moderate hallucinations; 5 severe hallucinations;
6 – extremely severe hallucinations; 7 - continuous
hallucinations

Auditory Disturbances (0 - 7)
0 - not present; 1 - very mild harshness/ ability to startle;
2 - mild harshness, ability to startle; 3 - moderate
harshness, ability to startle; 4 - moderate hallucinations;
5 severe hallucinations;
6 - extremely severe hallucinations; 7 continuous.hallucinations

Visual Disturbances (0 - 7)
0 - not present; 1 - very mild sensitivity;
2 - mild
sensitivity;
3 - moderate sensitivity;
4 - moderate hallucinations; 5 severe hallucinations;
6 - extremely severe
hallucinations; 7 - continuous hallucinations

Headache (0 - 7)
0 - not present; 1 - very mild; 2 - mild; 3 - moderate; 4 moderately severe; 5 - severe; 6 - very severe; 7 - extremely
severe

Total CIWA-Ar score:
PRN Med: (circle
one) Diazepam
Loraze
pam

Dose given
(mg):
Route:

Time of PRN medication
administration:

Refer to reverse for detailed instructions in use of the CIWA-Ar
scale.
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Assessment of response (CIWA-Ar score
30-60
minutes after medication administered)
RN Initials
Scale for Scoring:
Total Score =
0 – 9: absent or minimal
withdrawal 10 – 19: mild to
moderate withdrawal more
than 20: severe withdrawal

Indications for PRN medication:
a. Total CIWA-AR score 8 or higher if ordered PRN only (Symptom-triggered method).
b. Total CIWA-Ar score 15 or higher if on Scheduled medication. (Scheduled + prn
method) Consider transfer to ICU for any of the following: Total score above 35, q1h
assess. x more than 8hrs required, more than 4 mg/hr lorazepam x 3hr or 20 mg/hr
diazepam x 3hr required, or resp. distress.

Patient Identification (Addressograph)

Signature/ Title

Initials

Signature / Title

Alcohol Withdrawal Assessment Flowsheet (revised Nov 2003)

Initials

